CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,360,000 | -77.8% | 585,394 | -72.0% | 0.15% | -82.8% |
| Q3 2020 | $15,127,000 | +107.4% | 2,089,356 | 0.0% | 0.87% | +67.1% |
| Q2 2020 | $7,292,000 | +357.2% | 2,089,356 | +93.9% | 0.52% | +263.2% |
| Q1 2020 | $1,595,000 | -89.7% | 1,077,467 | -50.0% | 0.14% | -90.0% |
| Q2 2019 | $15,429,000 | -43.5% | 2,154,934 | +4.8% | 1.45% | -46.9% |
| Q1 2019 | $27,304,000 | +282.9% | 2,056,000 | +126.9% | 2.72% | +198.9% |
| Q4 2018 | $7,130,000 | -29.0% | 906,000 | 0.0% | 0.91% | -10.0% |
| Q3 2018 | $10,038,000 | -17.4% | 906,000 | 0.0% | 1.01% | -35.4% |
| Q2 2018 | $12,158,000 | +17.0% | 906,000 | +13.2% | 1.57% | +6.5% |
| Q1 2018 | $10,392,000 | – | 800,000 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |